New Gout Drugs Might Increase Patients at Target Urate Level - Medscape
Jul 9, 2024 · New options in late stages of clinical testing for refractory gout promise to increase the chances of reaching the guideline uric acid target with relatively modest risks for adverse events.
Groundbreaking Study Shatters Gout Myths: Genetics, Not
Oct 18, 2024 · New research has found that genetics, not lifestyle, is the primary cause of gout. The study identified key genes and immune pathways, opening the door to improved treatments and challenging the stigma that links gout to poor lifestyle choices.
Emerging therapeutic options for refractory gout - Nature
Dec 15, 2023 · For individuals with gout, the treatment options beyond conventional urate-lowering therapies are expanding. Notable advancements in 2023 include developments in uricase therapy, new xanthine...
Gut Microbiome Has Potential to Counter Gout - Medscape
1 day ago · Efforts to combat hyperuricemia may find help from gut microbes, according to Dylan Dodd, MD, PhD, who spoke at the annual research symposium of the Gout, Hyperuricemia, and Crystal-Associated ...
Gout may be caused by deficiency of a protein found in joint fluid
Mar 19, 2023 · Researchers say a deficiency of a protein known as lubricin in joint fluid may be a factor in causing gout. The discovery could potentially lead to new treatments.
'Horribly mismanaged': Debate over gout treatment rages as
Feb 24, 2022 · All around the world, gout prevalence is growing at an alarming pace, while gout treatment remains as “horribly mismanaged” as ever.
FDA Approves Canakinumab to Treat Gout Flares
Nov 3, 2023 · On Aug. 25, the U.S. Food & Drug Administration (FDA) approved canakinumab (Ilaris) for the treatment of gout flares in adult patients who can’t tolerate non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, or for whom NSAIDs and colchicine are contraindicated or provide an inadequate response.
Target These Serum Urate Levels to Prevent Gout Flares - Medscape
Feb 6, 2024 · Clinical efforts to get patients with a history of gout to reach specific target serum urate (SU) levels less than either 5 or 6 mg/dL could prevent the great majority of gout flares and...
Gout - Latest research and news | Nature
Oct 15, 2024 · Gout is a form of recurrent inflammatory arthritis caused by hyperuricaemia and subsequent accumulation of monosodium urate crystal deposition in the joints, tendons and surrounding tissues.
Gout increases the risk of a broad range of cardiovascular diseases
Feb 20, 2024 · Gout is associated with an increased risk of a broad range of cardiovascular diseases, according to new research which looked at the health records of more than 860,000 people.
- Some results have been removed